Emerson Electric Statistics
Total Valuation
EMR has a market cap or net worth of $62.05 billion. The enterprise value is $76.41 billion.
| Market Cap | 62.05B |
| Enterprise Value | 76.41B |
Important Dates
The next confirmed earnings date is Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
EMR has 572.10 million shares outstanding. The number of shares has decreased by -1.36% in one year.
| Shares Outstanding | 572.10M |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 79.31% |
| Float | 569.66M |
Valuation Ratios
The trailing PE ratio is 36.62 and the forward PE ratio is 18.89. EMR's PEG ratio is 1.40.
| PE Ratio | 36.62 |
| Forward PE | 18.89 |
| PS Ratio | 3.65 |
| Forward PS | 3.39 |
| PB Ratio | 2.98 |
| P/FCF Ratio | 52.36 |
| PEG Ratio | 1.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.39, with an EV/FCF ratio of 64.48.
| EV / Earnings | 44.53 |
| EV / Sales | 4.50 |
| EV / EBITDA | 17.39 |
| EV / EBIT | 25.91 |
| EV / FCF | 64.48 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.40.
| Current Ratio | 1.16 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.33 |
| Debt / FCF | 9.09 |
| Interest Coverage | 9.33 |
Financial Efficiency
Return on equity (ROE) is 6.47% and return on invested capital (ROIC) is 5.07%.
| Return on Equity (ROE) | 6.47% |
| Return on Assets (ROA) | 4.11% |
| Return on Capital (ROIC) | 5.07% |
| Revenue Per Employee | $253,179 |
| Profits Per Employee | $25,612 |
| Employee Count | 67,000 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 3.74 |
Taxes
In the past 12 months, EMR has paid $465.00 million in taxes.
| Income Tax | 465.00M |
| Effective Tax Rate | 21.29% |
Stock Price Statistics
The stock price has increased by +21.91% in the last 52 weeks. The beta is 1.29, so EMR's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +21.91% |
| 50-Day Moving Average | 106.65 |
| 200-Day Moving Average | 108.10 |
| Relative Strength Index (RSI) | 48.64 |
| Average Volume (20 Days) | 2,122,136 |
Short Selling Information
The latest short interest is 8.63 million, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 8.63M |
| Short Previous Month | 7.03M |
| Short % of Shares Out | 1.51% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, EMR had revenue of $16.96 billion and earned $1.72 billion in profits. Earnings per share was $2.97.
| Revenue | 16.96B |
| Gross Profit | 8.76B |
| Operating Income | 2.95B |
| Pretax Income | 2.17B |
| Net Income | 1.72B |
| EBITDA | 4.39B |
| EBIT | 2.95B |
| Earnings Per Share (EPS) | $2.97 |
Balance Sheet
The company has $2.30 billion in cash and $10.77 billion in debt, giving a net cash position of -$8.47 billion or -$14.80 per share.
| Cash & Cash Equivalents | 2.30B |
| Total Debt | 10.77B |
| Net Cash | -8.47B |
| Net Cash Per Share | -$14.80 |
| Equity (Book Value) | 26.69B |
| Book Value Per Share | 36.36 |
| Working Capital | 1.23B |
Cash Flow
In the last 12 months, operating cash flow was $1.61 billion and capital expenditures -$420.00 million, giving a free cash flow of $1.19 billion.
| Operating Cash Flow | 1.61B |
| Capital Expenditures | -420.00M |
| Free Cash Flow | 1.19B |
| FCF Per Share | $2.07 |
Margins
Gross margin is 51.62%, with operating and profit margins of 17.38% and 10.12%.
| Gross Margin | 51.62% |
| Operating Margin | 17.38% |
| Pretax Margin | 12.88% |
| Profit Margin | 10.12% |
| EBITDA Margin | 25.90% |
| EBIT Margin | 17.38% |
| FCF Margin | 6.99% |
Dividends & Yields
This stock pays an annual dividend of $2.10, which amounts to a dividend yield of 1.94%.
| Dividend Per Share | $2.10 |
| Dividend Yield | 1.94% |
| Dividend Growth (YoY) | 0.96% |
| Years of Dividend Growth | 67 |
| Payout Ratio | 70.66% |
| Buyback Yield | 1.36% |
| Shareholder Yield | 3.29% |
| Earnings Yield | 2.77% |
| FCF Yield | 1.91% |
Analyst Forecast
The average price target for EMR is $125.81, which is 16.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $125.81 |
| Price Target Difference | 16.00% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 8.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 12, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 12, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
EMR has an Altman Z-Score of 3.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 6 |